AU2001255580A1 - Methods and compositions for the diagnosis of schizophrenia - Google Patents
Methods and compositions for the diagnosis of schizophreniaInfo
- Publication number
- AU2001255580A1 AU2001255580A1 AU2001255580A AU5558001A AU2001255580A1 AU 2001255580 A1 AU2001255580 A1 AU 2001255580A1 AU 2001255580 A AU2001255580 A AU 2001255580A AU 5558001 A AU5558001 A AU 5558001A AU 2001255580 A1 AU2001255580 A1 AU 2001255580A1
- Authority
- AU
- Australia
- Prior art keywords
- schizophrenia
- diagnosis
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19889300P | 2000-04-21 | 2000-04-21 | |
US60198893 | 2000-04-21 | ||
PCT/US2001/013019 WO2001091625A2 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001255580A1 true AU2001255580A1 (en) | 2001-12-11 |
Family
ID=22735308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001255580A Abandoned AU2001255580A1 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001255580A1 (en) |
WO (1) | WO2001091625A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072761A1 (en) * | 2002-02-22 | 2003-09-04 | Human Genome Sciences, Inc. | 20 human secreted proteins |
WO2006036445A2 (en) | 2004-09-24 | 2006-04-06 | Trustees Of Dartmouth College | Chimeric nk receptor and methods for treating cancer |
WO2018148224A1 (en) | 2017-02-07 | 2018-08-16 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Phospholipid ether (ple) car t cell tumor targeting (ctct) agents |
US11850262B2 (en) | 2017-02-28 | 2023-12-26 | Purdue Research Foundation | Compositions and methods for CAR T cell therapy |
CN112055595A (en) | 2018-01-22 | 2020-12-08 | 恩多塞特公司 | Methods of use of CAR T cells |
HUP1800441A1 (en) | 2018-12-21 | 2020-06-29 | Ferenc Benesch | Activee chair, primarily for office use |
-
2001
- 2001-04-23 AU AU2001255580A patent/AU2001255580A1/en not_active Abandoned
- 2001-04-23 WO PCT/US2001/013019 patent/WO2001091625A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001091625A3 (en) | 2002-05-23 |
WO2001091625A2 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU2001295503A1 (en) | Composition for the elimination of autoreactive b-cells | |
AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
AU2001278852A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
AU2001249444A1 (en) | Methods and compositions for the simultaneous detection of multiple analytes | |
AU2001247196A1 (en) | Methods and compositions for detection of disease | |
AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2002249983A1 (en) | Compositions and methods for diagnosis of neuropsychiatric disorders | |
AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU2001257164A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001255597A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001257180A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001257179A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001255606A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001259127A1 (en) | Methods and composition for the diagnosis of schizophrenia | |
AU2001257175A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001255589A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001255585A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001257183A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU2001257176A1 (en) | Methods and compositions for the diagnosis of schizophrenia |